Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety (NCT06256146)
🩺 Plain-English Summary (8th-Grade Level)
Protocols for Oral Immunotherapy (OIT) for the main food allergens have been recently incorporated in clinical practice for food allergies and their clinical benefits have been acknowledged in European and Canadian official guidelines. There has been some reluctance in both clinicians and patients to implement these therapies, primarily because of the risk of allergic reactions during the desensitization process. This study will investigate if protocols using low doses of a food allergen or processed versions of the allergen can be both effective in conferring desensitization while inducing fewer allergic symptoms during the desensitization process.
Who can join: Review the eligibility criteria below.
Location: Research Institute of the McGill University Health Centre — Montreal, Quebec
Age range: 2 Years to 40 Years
🧪 Interventions in This Study
- Food allergy desensitization / Oral Immunotherapy (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Research Institute of the McGill University Health Centre — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (514) 934-1934
Email: duncan.lejtenyi@muhc.mcgill.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peanut Allergy
- Food Oral Immunotherapy for Peanut Allergy — Boston, Massachusetts
- A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy — Little Rock, Arkansas
- Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects — Tucson, Arizona
- Peanut and Tree Nut Desensitization — Toronto, Ontario
- Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy — Montreal, Quebec
Explore by condition: All Peanut Allergy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.